Vida Health’s Post

View organization page for Vida Health, graphic

37,017 followers

In Pharmaceutical Strategies Group - PSG Trends in Drug Benefit Design Report, only 29% of respondents who reported their plan covers GLP-1s for obesity require participation in a lifestyle modification program and only 32% have implemented a step therapy approach. If cost containment is truly such a concern, why are these strategies being used by less than 1/3 of the respondents?

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics